-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Buy on Edwards Lifesciences, Lowers Price Target to $95

Benzinga·02/11/2026 17:41:46
Listen to the news
Goldman Sachs analyst David Roman maintains Edwards Lifesciences (NYSE:EW) with a Buy and lowers the price target from $108 to $95.